Israel - heprea - Ministry of Health

abic veterinary products ltd - lincomycin as hydrochloride 33.3 g; spectinomycin as sulfate 66.7 g - powder soluble - for the treatment chronic respiratory diseases caused by microorganisms susceptible to the preparation in turkeys.

Israel - heprea - Ministry of Health

romat ltd - lincomycin hydrochloride 56.7 mg/ml; spectinomycin hydrochloride 150 mg/ml - solution for injection - for infections caused by the following bacteria: staphylocococcus spp, streptococcus spp, diplococcus spp., corynebacterium spp., bacillus spp.,clostridium spp., coliform bacteria, klebsiella spp., salmonella spp., haemophilus spp., brucella spp., pasteurella spp., leptospira spp., bordetella spp., coccidia, campylobacter spp., fusobacterium spp., treponema spp., mycoplasma spp. cattle: respiratory diseased, enteritis, foot infections, mastitis, clostridiosis, mycoplasmosis. swine: pneumonia (bacteria/mycoplasma), bloody scours, septic arthritis, bacterial enteritis, pneumonia (haemophilus).

Israel - heprea - Ministry of Health

pfizer pharmaceuticals israel ltd - etanercept - תמיסה להזרקה - etanercept 50 mg/ml - etanercept - etanercept - * rheumatoid arthritis:enbrel is indicated for the treatment of active rhematoid arthritis in adults when the response to disease-modifying antirheumatic drugs (dmards) including methotrexate (unless contraindicated) has been inadequate.. enbrel can be used in combination with methotrexate in patients who do not respond adequately to methotrexate alone. reducing signs and symptoms and inhibiting the progression of structural damage in patients with moderately to severely active rheumatoid arthritis.enbrel, alone or in combination with methotrexate, has been shown to reduce the rate of progression of joint damage as measured by x-ray and to improve physical function.* polyarticular juvenile idiopathic arthritis: treatment of active polyarticular juvenile idiopathic arthritis in children and adolescents from the age of 2 years who have had an inadequate response to, or who have proved intolerant of, methotrexate. enbrel has not been studied in children aged less than 2 years.* psoriatic arthritistreatment of ac

Israel - heprea - Ministry of Health

pfizer pharmaceuticals israel ltd - etanercept - תמיסה להזרקה - etanercept 50 mg/ml - etanercept - etanercept - * rheumatoid arthritis:enbrel is indicated for the treatment of active rhematoid arthritis in adults when the response to disease-modifying antirheumatic drugs (dmards) including methotrexate (unless contraindicated) has been inadequate.. enbrel can be used in combination with methotrexate in patients who do not respond adequately to methotrexate alone. reducing signs and symptoms and inhibiting the progression of structural damage in patients with moderately to severely active rheumatoid arthritis.enbrel, alone or in combination with methotrexate, has been shown to reduce the rate of progression of joint damage as measured by x-ray and to improve physical function.* polyarticular juvenile idiopathic arthritis: treatment of active polyarticular juvenile idiopathic arthritis in children and adolescents from the age of 2 years who have had an inadequate response to, or who have proved intolerant of, methotrexate. enbrel has not been studied in children aged less than 2 years.* psoriatic arthritistreatment of ac

Israel - heprea - Ministry of Health

novartis israel ltd - etanercept - תמיסה להזרקה - etanercept 25 mg / 0.5 ml - etanercept

Israel - heprea - Ministry of Health

novartis israel ltd - etanercept - תמיסה להזרקה - etanercept 50 mg / 1 ml - etanercept

Israel - heprea - Ministry of Health

tradis gat ltd - fidaxomicin - טבליות מצופות פילם - fidaxomicin 200 mg - fidaxomicin

Israel - heprea - Ministry of Health

pfizer pfe pharmaceuticals israel ltd - sulfasalazine - טבליות עם ציפוי אנטרי - sulfasalazine 500 mg - sulfasalazine - sulfasalazine - for active rheumatoid arthritis which is not controlled by antiinflammatory drugs. ulcerative colitis, crohn's disease, pyoderma gangrenosum.

Israel - heprea - Ministry of Health

pfizer pfe pharmaceuticals israel ltd - sulfasalazine - טבליה - sulfasalazine 500 mg - sulfasalazine - sulfasalazine - treatment of ulcerative colitis and crohn's disease.

Israel - heprea - Ministry of Health

perrigo israel agencies ltd - benzoyl peroxide; erythromycin - ג'ל - benzoyl peroxide 87.125 mg/g; erythromycin 0.8 g - benzoyl peroxide, combinations - benzoyl peroxide, combinations - for topical treatment of acne vulgaris.